A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities

• Main Authors: Danielle Vaughan (Author), Robert Mitchell (Author), Oliver Kretz (Author), David Chambers (Author), Maciej Lalowski (Author), Helge Amthor (Author), Olli Ritvos (Author), Arja Pasternack (Author), Antonios Matsakas (Author), Sakthivel Vaiyapuri (Author), Tobias B. Huber (Author), Bernd Denecke (Author), Abir Mukherjee (Author), Darius Widera (Author), Ketan Patel (Author)
• Format: Book
• Published: The Company of Biologists, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Activin/myostatin signalling acts to induce skeletal muscle atrophy in adult mammals by inhibiting protein synthesis as well as promoting protein and organelle turnover. Numerous strategies have been successfully developed to attenuate the signalling properties of these molecules, which result in au...